Jade Biosciences, Inc.
Recent Filings
All 461 filings →| Form | Description | Date |
|---|---|---|
| S-8 | S-8 | Mar 6, 2026 |
| POS EX | POS EX | Mar 6, 2026 |
| POS EX | POS EX | Mar 6, 2026 |
| 424B3 | 424B3 | Mar 6, 2026 |
| 424B3 | 424B3 | Mar 6, 2026 |
| 10-K | 10-K | Mar 6, 2026 |
| 8-K | 8-K | Mar 6, 2026 |
| SCHEDULE 13D/A | — | Mar 5, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Fairmount Healthcare Fund II L.P. | — | Award / Grant | 1,333,126 @ $9.14 | 1,897,677 | Oct 6, 2025 |
| Frohlich Tom | Chief Executive Officer | Purchase | 6,000 @ $7.40 | 6,000 | May 16, 2025 |
| Shah Rajeev M. | — | Purchase | 928,110 @ $1.67 | 7,893,678 | Jun 17, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 8,707 @ $21.52 | 1,293 | May 16, 2024 |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | Sale | 1,981 @ $21.02 | — | May 2, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 1,357 @ $19.91 | — | May 1, 2024 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Sale | 3,689 @ $22.30 | 3,562 | Apr 17, 2024 |
| GRAYZEL DAVID S. | — | Sale | 11,882 @ $28.15 | 14,502 | Apr 9, 2024 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 1,647 @ $29.90 | 3,851 | Apr 1, 2024 |
| Eldridge George A | SEE REMARKS | Sale | 12,495 @ $31.23 | 1,960 | Apr 1, 2024 |